14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $22.23 $23.98 Thursday, 25th Apr 2024 EXEL stock ended at $23.53. This is 0.759% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 1.65% from a day low at $23.36 to a day high of $23.74.
90 days $20.02 $24.07
52 weeks $18.08 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
Mar 20, 2024 $23.41 $23.73 $23.28 $23.71 2 205 806
Mar 19, 2024 $23.19 $23.51 $23.18 $23.47 2 326 922
Mar 18, 2024 $23.14 $23.42 $23.07 $23.17 2 292 087
Mar 15, 2024 $22.62 $23.02 $22.55 $22.98 4 563 606
Mar 14, 2024 $23.02 $23.10 $22.40 $22.61 2 429 942
Mar 13, 2024 $22.77 $23.19 $22.77 $23.07 2 588 083
Mar 12, 2024 $22.42 $22.71 $22.32 $22.69 1 979 758
Mar 11, 2024 $22.34 $22.59 $22.24 $22.46 2 116 428
Mar 08, 2024 $22.12 $22.38 $22.05 $22.21 1 320 275
Mar 07, 2024 $22.49 $22.51 $22.08 $22.09 1 798 588
Mar 06, 2024 $22.33 $22.54 $22.31 $22.38 1 844 907
Mar 05, 2024 $22.57 $22.81 $22.24 $22.26 2 415 755
Mar 04, 2024 $22.48 $22.66 $22.23 $22.55 2 205 848
Mar 01, 2024 $22.01 $22.63 $22.01 $22.24 3 368 230
Feb 29, 2024 $22.08 $22.25 $21.88 $21.90 3 141 473
Feb 28, 2024 $21.64 $22.04 $21.49 $21.91 2 351 030
Feb 27, 2024 $21.97 $22.03 $21.61 $21.71 2 483 700
Feb 26, 2024 $21.49 $21.99 $21.49 $21.96 2 173 763
Feb 23, 2024 $21.29 $21.78 $21.15 $21.53 2 637 810
Feb 22, 2024 $20.72 $20.88 $20.49 $20.71 1 782 677
Feb 21, 2024 $20.59 $20.78 $20.57 $20.72 1 945 930
Feb 20, 2024 $20.45 $20.81 $20.43 $20.63 1 944 591
Feb 16, 2024 $20.56 $20.84 $20.38 $20.48 2 388 570
Feb 15, 2024 $20.52 $20.91 $20.44 $20.59 2 360 934
Feb 14, 2024 $20.27 $20.58 $20.22 $20.39 2 035 411
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT